Title : The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies.

Pub. Date : 2022 Mar

PMID : 35228013






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 When AZD2816 is used as a booster dose in animals primed with a vaccine encoding the original spike protein (ChAdOx1 nCoV-19/ (AZD1222)), an increase in binding and neutralising antibodies against Beta (B.1.351), Gamma (P.1) and Delta (B.1.617.2) is observed following each additional dose. azd1222 surface glycoprotein Severe acute respiratory syndrome coronavirus 2